Advanced search
Publication Cover
Cancer Management and Research Volume 11, 2019 - Issue
Submit an article Journal homepage
88
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Postoperative metastasis prediction based on portal vein circulating tumor cells detected by flow cytometry in periampullary or pancreatic cancer

Lianyuan Tao1 Department of General Surgery, Peking University Third Hospital, Beijing100191, People’s Republic of China;2 Department of Hepatobiliary Surgery, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou, Henan450003, People’s Republic of China
,
Li Su3 Medical and Health Analytical Center, Peking University Health Science Center, Beijing100191, People’s Republic of China
,
Chunhui Yuan1 Department of General Surgery, Peking University Third Hospital, Beijing100191, People’s Republic of China
,
Zhaolai Ma1 Department of General Surgery, Peking University Third Hospital, Beijing100191, People’s Republic of China
,
Lingfu Zhang1 Department of General Surgery, Peking University Third Hospital, Beijing100191, People’s Republic of China
,
Shiping Bo4 Department of Clinical Research, Yikon Genomics Co. Ltd., Shanghai, People’s Republic of China
,
Yunyun Niu4 Department of Clinical Research, Yikon Genomics Co. Ltd., Shanghai, People’s Republic of China
,
Sijia Lu4 Department of Clinical Research, Yikon Genomics Co. Ltd., Shanghai, People’s Republic of China
&
Dianrong Xiu1 Department of General Surgery, Peking University Third Hospital, Beijing100191, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 7405-7425 | Published online: 06 Aug 2019

References

  • Dimastromatteo J, Houghton JL, Lewis JS, Kelly KA. Challenges of pancreatic cancer. Cancer J. 2015;21:188–193. doi:10.1097/PPO.000000000000010926049698
  • Hidalgo M. Pancreatic cancer. N Engl J Med. 2010;362:1605–1617. doi:10.1056/NEJMra090155720427809
  • Zhang Q, Zeng L, Chen Y, et al. Pancreatic cancer epidemiology, detection, and management. Gastroenterol Res Pract. 2016;2016:8962321. doi:10.1155/2016/896232126941789
  • Long J, Luo GP, Xiao ZW, et al. Cancer statistics: current diagnosis and treatment of pancreatic cancer in Shanghai, China. Cancer Lett. 2014;346:273–277. doi:10.1016/j.canlet.2014.01.00424462819
  • Chen SC, Shyr YM, Wang SE. Longterm survival after pancreaticoduodenectomy for periampullary adenocarcinomas. HPB (Oxford). 2013;15:951–957. doi:10.1111/hpb.1207123472708
  • Riall TS, Cameron JL, Lillemoe KD, et al. Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up. Surgery. 2006;140:764–772. doi:10.1016/j.surg.2006.04.00617084719
  • Tao L, Zhang L, Peng Y, et al. Neutrophils assist the metastasis of circulating tumor cells in pancreatic ductal adenocarcinoma: a new hypothesis and a new predictor for distant metastasis. Medicine (Baltimore). 2016;95:e4932. doi:10.1097/MD.000000000000486427684834
  • Erdmann JI, Morak MJ, Duivenvoorden HJ, et al. Long-term survival after resection for non-pancreatic periampullary cancer followed by adjuvant intra-arterial chemotherapy and concomitant radiotherapy. HPB (Oxford). 2015;17:573–579. doi:10.1111/hpb.1240125800041
  • Chen XX, Bai F. Single-cell analyses of circulating tumor cells. Cancer Biol Med. 2015;12:184–192. doi:10.7497/j.issn.2095-3941.2015.005626487963
  • Joosse SA, Gorges TM, Pantel K. Biology, detection, and clinical implications of circulating tumor cells. EMBO Mol Med. 2015;7:1–11. doi:10.15252/emmm.20130369825398926
  • Han L, Chen W, Zhao Q. Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis. Tumour Biol. 2014;35:2473–2480. doi:10.1007/s13277-013-1327-524218336
  • Bissolati M, Sandri MT, Burtulo G, Zorzino L, Balzano G, Braga M. Portal vein-circulating tumor cells predict liver metastases in patients with resectable pancreatic cancer. Tumour Biol. 2015;36:991–996. doi:10.1007/s13277-014-2716-025318603
  • Tien YW, Kuo HC, Ho BI, et al. A high circulating tumor cell count in portal vein predicts liver metastasis from periampullary or pancreatic cancer: a high portal venous CTC count predicts liver metastases. Medicine (Baltimore). 2016;95:e3407. doi:10.1097/MD.000000000000486427100430
  • Liu X, Li C, Li J, et al. Detection of CTCs in portal vein was associated with intrahepatic metastases and prognosis in patients with advanced pancreatic cancer. J Cancer. 2018;9:2038–2045. doi:10.7150/jca.2398929896289
  • Hugenschmidt H, Labori KJ, Brunborg C, et al. Circulating tumor cells are an independent predictor of shorter survival in patients undergoing resection for pancreatic and periampullary adenocarcinoma. Ann Surg. 2018. doi:10.1097/SLA.0000000000003035
  • Vilhav C, Engstrom C, Naredi P, et al. Fractional uptake of circulating tumor cells into liver-lung compartments during curative resection of periampullary cancer. Oncol Lett. 2018;16:6331–6338. doi:10.3892/ol.2018.943530405768
  • Adams DL, Stefansson S, Haudenschild C, et al. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the cellSearch((R)) CTC test. Cytometry A. 2015;87:137–144. doi:10.1002/cyto.a.2261325515318
  • Dong Y, Skelley AM, Merdek KD, et al. Microfluidics and circulating tumor cells. J Mol Diagn. 2013;15:149–157. doi:10.1016/j.jmoldx.2012.09.00423266318
  • Khoja L, Backen A, Sloane R, et al. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer. 2012;106:508–516. doi:10.1038/bjc.2011.54522187035
  • Lu Y, Liang H, Yu T, et al. Isolation and characterization of living circulating tumor cells in patients by immunomagnetic negative enrichment coupled with flow cytometry. Cancer. 2015;121:3036–3045. doi:10.1002/cncr.2944425945459
  • Edge SB, Compton CC. The American joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471–1474. doi:10.1245/s10434-010-0985-420180029
  • Pinto LA, Trivett MT, Wallace D, et al. Fixation and cryopreservation of whole blood and isolated mononuclear cells: influence of different procedures on lymphocyte subset analysis by flow cytometry. Cytometry B Clin Cytom. 2005;63:47–55. doi:10.1002/cyto.b.2003815624203
  • Zong C, Lu S, Chapman AR, Xie XS. Genome-wide detection of single-nucleotide and copy-number variations of a single human cell. Science. 2012;338:1622–1626. doi:10.1126/science.122916423258894
  • Huang L, Ma F, Chapman A, Lu S, Xie XS. Single-cell whole-genome amplification and sequencing: methodology and applications. Annu Rev Genomics Hum Genet. 2015;16:79–102. doi:10.1146/annurev-genom-090413-02535226077818
  • Ni X, Zhuo M, Su Z, et al. Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients. Proc Natl Acad Sci U S A. 2013;110:21083–21088. doi:10.1073/pnas.132065911024324171
  • Yuan J, Zhou J, Dong Z, et al. Pretreatment serum VEGF is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab. Cancer Immunol Res. 2014;2:127–132. doi:10.1158/2326-6066.CIR-13-016324778276
  • Kim MS, Zhong Y, Yachida S, et al. Heterogeneity of pancreatic cancer metastases in a single patient revealed by quantitative proteomics. Mol Cell Proteomics. 2014;13:2803–2811. doi:10.1074/mcp.M114.03854724895378
  • Cros J, Raffenne J, Couvelard A, et al. Tumor heterogeneity in pancreatic adenocarcinoma. Pathobiology. 2018;85:64–71. doi:10.1159/000477773
  • Lapin M, Tjensvoll K, Oltedal S, et al. Single-cell mRNA profiling reveals transcriptional heterogeneity among pancreatic circulating tumour cells. BMC Cancer. 2017;17:390. doi:10.1186/s12885-017-3385-328569190
  • Catenacci DV, Chapman CG, Xu P, et al. Acquisition of portal venous circulating tumor cells from patients with pancreaticobiliary cancers by endoscopic ultrasound. Gastroenterology. 2015;149:1794–1803 e4. doi:10.1053/j.gastro.2015.08.05026341722
  • Hong Y, Fang F, Zhang Q. Circulating tumor cell clusters: what we know and what we expect (Review). Int J Oncol. 2016;49:2206–2216. doi:10.3892/ijo.2016.374727779656
  • Labelle M, Hynes RO. The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. Cancer Discov. 2012;2:1091–1099. doi:10.1158/2159-8290.CD-12-032923166151
  • Patel LR, Camacho DF, Shiozawa Y, Pienta KJ, Taichman RS. Mechanisms of cancer cell metastasis to the bone: a multistep process. Future Oncol. 2011;7:1285–1297. doi:10.2217/fon.11.11222044203
  • Ni XG, Bai XF, Mao YL, et al. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer. Eur J Surg Oncol. 2005;31:164–169. doi:10.1016/j.ejso.2004.09.00715698733
  • Tao LY, Cai L, He XD, Liu W, Qu Q. Comparison of serum tumor markers for intrahepatic cholangiocarcinoma and hepatocellular carcinoma. Am Surg. 2010;76:1210–1213.21140686

Reference

  • Shaffer LG, McGowan-Jordan J, Schmid M, editors. An International System for Human Cytogenetic Nomenclature (2013). Basel: Karger Publishers; 2013.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.